Literature DB >> 23255113

Depletion of Aurora A leads to upregulation of FoxO1 to induce cell cycle arrest in hepatocellular carcinoma cells.

Sun-Young Lee1, Gong Rak Lee, Dong-Hyuk Woo, Neung Hwa Park, Hee Jeong Cha, Yong-Hwan Moon, In-Seob Han.   

Abstract

Aurora A kinase has drawn considerable attention as a therapeutic target for cancer therapy. However, the underlying molecular and cellular mechanisms of the anticancer effects of Aurora A kinase inhibition are still not fully understood. Herein, we show that depletion of Aurora A kinase by RNA interference (RNAi) in hepatocellular carcinoma (HCC) cells upregulated FoxO1 in a p53-dependent manner, which induces cell cycle arrest. Introduction of an RNAi-resistant Aurora A kinase into Aurora A-knockdown cells resulted in downregulation of FoxO1 expression and rescued proliferation. In addition, silencing of FoxO1 in Aurora A-knockdown cells allowed the cells to exit cytostatic arrest, which, in turn, led to massive cell death. Our results suggest that FoxO1 is responsible for growth arrest at the G2/M phase that is induced by Aurora A kinase inhibition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23255113      PMCID: PMC3570518          DOI: 10.4161/cc.22962

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

1.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1.

Authors:  R H Medema; G J Kops; J L Bos; B M Burgering
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress.

Authors:  Yoko Furukawa-Hibi; Kiyomi Yoshida-Araki; Tsutomu Ohta; Kyoji Ikeda; Noboru Motoyama
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

Review 3.  The cellular geography of aurora kinases.

Authors:  Mar Carmena; William C Earnshaw
Journal:  Nat Rev Mol Cell Biol       Date:  2003-11       Impact factor: 94.444

4.  Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells.

Authors:  Toru Hirota; Naoko Kunitoku; Takashi Sasayama; Tomotoshi Marumoto; Dongwei Zhang; Masayuki Nitta; Katsuyoshi Hatakeyama; Hideyuki Saya
Journal:  Cell       Date:  2003-09-05       Impact factor: 41.582

5.  Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors.

Authors:  Geert J P L Kops; Rene H Medema; Janet Glassford; Marieke A G Essers; Pascale F Dijkers; Paul J Coffer; Eric W-F Lam; Boudewijn M T Burgering
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

6.  Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.

Authors:  Kevin R Kelly; Steffan T Nawrocki; Claudia M Espitia; Mengkun Zhang; Johnny J Yang; Swaminathan Padmanabhan; Jeffrey Ecsedy; Francis J Giles; Jennifer S Carew
Journal:  Int J Cancer       Date:  2012-06-28       Impact factor: 7.396

7.  Forkhead transcription factors contribute to execution of the mitotic programme in mammals.

Authors:  B Alvarez; C Martínez-A; B M Burgering; A C Carrera
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

Review 8.  Targeting Aurora-2 kinase in cancer.

Authors:  Steven L Warner; David J Bearss; Haiyong Han; Daniel D Von Hoff
Journal:  Mol Cancer Ther       Date:  2003-06       Impact factor: 6.261

9.  Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.

Authors:  Donghui Li; Jijiang Zhu; Pervez F Firozi; James L Abbruzzese; Douglas B Evans; Karen Cleary; Helmut Friess; Subrata Sen
Journal:  Clin Cancer Res       Date:  2003-03       Impact factor: 12.531

10.  Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation.

Authors:  C Sakakura; A Hagiwara; R Yasuoka; Y Fujita; M Nakanishi; K Masuda; K Shimomura; Y Nakamura; J Inazawa; T Abe; H Yamagishi
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

View more
  19 in total

1.  The function of FOXO1 in the late phases of the cell cycle is suppressed by PLK1-mediated phosphorylation.

Authors:  Chengfu Yuan; Lei Wang; Liang Zhou; Zheng Fu
Journal:  Cell Cycle       Date:  2014-01-09       Impact factor: 4.534

2.  Ring Finger Protein 125 Is an Anti-Proliferative Tumor Suppressor in Hepatocellular Carcinoma.

Authors:  Takahiro Kodama; Michiko Kodama; Nancy A Jenkins; Neal G Copeland; Huanhuan Joyce Chen; Zhubo Wei
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

3.  A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma.

Authors:  Hui Hu; Wei Huang; Hong Zhang; Jianye Li; Qiong Zhang; Ya-Ru Miao; Fei-Fei Hu; Lu Gan; Zhenhong Su; Xiangliang Yang; An-Yuan Guo
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

4.  The long non-coding RNA TSLC8 inhibits colorectal cancer by stabilizing puma.

Authors:  Zhian Du; Tao Yu; Meina Sun; Yun Chu; Gang Liu
Journal:  Cell Cycle       Date:  2020-11-20       Impact factor: 4.534

5.  NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.

Authors:  Jingyi Jiang; Zheng Liu; Chao Ge; Cong Chen; Fangyu Zhao; Hong Li; Taoyang Chen; Ming Yao; Jinjun Li
Journal:  J Biol Chem       Date:  2017-09-27       Impact factor: 5.157

Review 6.  FOXO1: Another avenue for treating digestive malignancy?

Authors:  Feiyu Shi; Tian Li; Zhi Liu; Kai Qu; Chengxin Shi; Yaguang Li; Qian Qin; Liang Cheng; Xin Jin; Tianyu Yu; Wencheng Di; Jianwen Que; Hongping Xia; Junjun She
Journal:  Semin Cancer Biol       Date:  2017-09-28       Impact factor: 15.707

7.  miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop.

Authors:  Y Zhang; J Dai; H Deng; H Wan; M Liu; J Wang; S Li; X Li; H Tang
Journal:  Br J Cancer       Date:  2014-11-25       Impact factor: 7.640

8.  Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma.

Authors:  Chao Tan; Shun Liu; Shengkui Tan; Xiaoyun Zeng; Hongping Yu; Anhua Li; Chunhua Bei; Xiaoqiang Qiu
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

9.  Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction.

Authors:  Ye Cheng; Yunqian Li; Chengyuan Ma; Yang Song; Haiyang Xu; Hongquan Yu; Songbai Xu; Qingchun Mu; Haisong Li; Yong Chen; Gang Zhao
Journal:  Oncotarget       Date:  2016-03-15

10.  Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.

Authors:  Tian-Huei Chu; Hoi-Hung Chan; Hsiao-Mei Kuo; Li-Fen Liu; Tsung-Hui Hu; Cheuk-Kwan Sun; Mei-Lang Kung; Shih-Wei Lin; E-Ming Wang; Yi-Ling Ma; Kwan-Hung Cheng; Kwok Hung Lai; Zhi-Hong Wen; Ping-I Hsu; Ming-Hong Tai
Journal:  Oncotarget       Date:  2014-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.